vs
Orthofix Medical Inc.（OFIX）与Penguin Solutions, Inc.（PENG）财务数据对比。点击上方公司名可切换其他公司
Penguin Solutions, Inc.的季度营收约是Orthofix Medical Inc.的1.6倍（$343.1M vs $219.9M），Penguin Solutions, Inc.净利率更高（1.5% vs -1.0%，领先2.5%），Orthofix Medical Inc.同比增速更快（2.0% vs 0.6%），Penguin Solutions, Inc.自由现金流更多（$28.2M vs $16.8M），过去两年Penguin Solutions, Inc.的营收复合增速更高（11.8% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
企鹅解决方案公司旗下的兰波集团以拉姆齐解决方案品牌开展业务，是一家美国企业，业务涵盖个人理财、领导力发展、人际关系管理与职业发展相关产品与服务。该公司由戴夫·拉姆齐与妻子莎伦于1991年创立，总部位于田纳西州富兰克林。
OFIX vs PENG — 直观对比
营收规模更大
PENG
是对方的1.6倍
$219.9M
营收增速更快
OFIX
高出1.4%
0.6%
净利率更高
PENG
高出2.5%
-1.0%
自由现金流更多
PENG
多$11.4M
$16.8M
两年增速更快
PENG
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $343.1M |
| 净利润 | $-2.2M | $5.3M |
| 毛利率 | 71.1% | 28.0% |
| 营业利润率 | 0.2% | 5.7% |
| 净利率 | -1.0% | 1.5% |
| 营收同比 | 2.0% | 0.6% |
| 净利润同比 | 92.4% | 1.0% |
| 每股收益（稀释后） | $-0.05 | $0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPENG
| Q4 25 | $219.9M | $343.1M | ||
| Q3 25 | $205.6M | $337.9M | ||
| Q2 25 | $203.1M | $324.3M | ||
| Q1 25 | $193.6M | $365.5M | ||
| Q4 24 | $215.7M | $341.1M | ||
| Q3 24 | $196.6M | $284.8M | ||
| Q2 24 | $198.6M | $300.6M | ||
| Q1 24 | $188.6M | — |
净利润OFIXPENG
| Q4 25 | $-2.2M | $5.3M | ||
| Q3 25 | $-22.8M | $9.4M | ||
| Q2 25 | $-14.1M | $2.7M | ||
| Q1 25 | $-53.1M | $8.1M | ||
| Q4 24 | $-29.1M | $5.2M | ||
| Q3 24 | $-27.4M | — | ||
| Q2 24 | $-33.4M | $5.6M | ||
| Q1 24 | $-36.0M | — |
毛利率OFIXPENG
| Q4 25 | 71.1% | 28.0% | ||
| Q3 25 | 72.2% | 28.6% | ||
| Q2 25 | 68.7% | 29.3% | ||
| Q1 25 | 62.8% | 28.6% | ||
| Q4 24 | 69.0% | 28.7% | ||
| Q3 24 | 68.7% | 28.8% | ||
| Q2 24 | 67.8% | 29.6% | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXPENG
| Q4 25 | 0.2% | 5.7% | ||
| Q3 25 | -8.3% | 3.7% | ||
| Q2 25 | -7.9% | 3.0% | ||
| Q1 25 | -25.2% | 5.1% | ||
| Q4 24 | -5.3% | 5.1% | ||
| Q3 24 | -9.6% | -1.2% | ||
| Q2 24 | -12.5% | 3.8% | ||
| Q1 24 | -15.6% | — |
净利率OFIXPENG
| Q4 25 | -1.0% | 1.5% | ||
| Q3 25 | -11.1% | 2.8% | ||
| Q2 25 | -6.9% | 0.8% | ||
| Q1 25 | -27.4% | 2.2% | ||
| Q4 24 | -13.5% | 1.5% | ||
| Q3 24 | -13.9% | — | ||
| Q2 24 | -16.8% | 1.9% | ||
| Q1 24 | -19.1% | — |
每股收益（稀释后）OFIXPENG
| Q4 25 | $-0.05 | $0.04 | ||
| Q3 25 | $-0.57 | $0.10 | ||
| Q2 25 | $-0.36 | $-0.01 | ||
| Q1 25 | $-1.35 | $0.09 | ||
| Q4 24 | $-0.76 | $0.10 | ||
| Q3 24 | $-0.71 | — | ||
| Q2 24 | $-0.88 | $0.10 | ||
| Q1 24 | $-0.95 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $461.5M |
| 总债务越低越好 | — | $462.3M |
| 股东权益账面价值 | $450.0M | $389.7M |
| 总资产 | $850.6M | $1.6B |
| 负债/权益比越低杠杆越低 | — | 1.19× |
8季度趋势，按日历期对齐
现金及短期投资OFIXPENG
| Q4 25 | $82.0M | $461.5M | ||
| Q3 25 | $62.9M | $453.8M | ||
| Q2 25 | $65.6M | $735.5M | ||
| Q1 25 | $58.0M | $647.0M | ||
| Q4 24 | $83.2M | $393.7M | ||
| Q3 24 | $30.1M | $389.5M | ||
| Q2 24 | $26.4M | $467.5M | ||
| Q1 24 | $27.0M | — |
总债务OFIXPENG
| Q4 25 | — | $462.3M | ||
| Q3 25 | $157.2M | $461.8M | ||
| Q2 25 | $157.0M | $659.5M | ||
| Q1 25 | $156.9M | $658.8M | ||
| Q4 24 | $157.0M | $658.1M | ||
| Q3 24 | $118.5M | $657.3M | ||
| Q2 24 | $118.0M | $667.0M | ||
| Q1 24 | $118.2M | — |
股东权益OFIXPENG
| Q4 25 | $450.0M | $389.7M | ||
| Q3 25 | $442.5M | $394.2M | ||
| Q2 25 | $458.3M | $584.8M | ||
| Q1 25 | $458.3M | $602.5M | ||
| Q4 24 | $503.1M | $400.4M | ||
| Q3 24 | $525.9M | $391.4M | ||
| Q2 24 | $546.0M | $423.4M | ||
| Q1 24 | $570.3M | — |
总资产OFIXPENG
| Q4 25 | $850.6M | $1.6B | ||
| Q3 25 | $832.6M | $1.6B | ||
| Q2 25 | $837.2M | $1.8B | ||
| Q1 25 | $823.1M | $1.8B | ||
| Q4 24 | $893.3M | $1.6B | ||
| Q3 24 | $867.9M | $1.5B | ||
| Q2 24 | $882.0M | $1.5B | ||
| Q1 24 | $906.0M | — |
负债/权益比OFIXPENG
| Q4 25 | — | 1.19× | ||
| Q3 25 | 0.36× | 1.17× | ||
| Q2 25 | 0.34× | 1.13× | ||
| Q1 25 | 0.34× | 1.09× | ||
| Q4 24 | 0.31× | 1.64× | ||
| Q3 24 | 0.23× | 1.68× | ||
| Q2 24 | 0.22× | 1.58× | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $31.1M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $28.2M |
| 自由现金流率自由现金流/营收 | 7.6% | 8.2% |
| 资本支出强度资本支出/营收 | 4.9% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 5.89× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $116.3M |
8季度趋势，按日历期对齐
经营现金流OFIXPENG
| Q4 25 | $27.7M | $31.1M | ||
| Q3 25 | $12.4M | $-70.4M | ||
| Q2 25 | $11.6M | $92.8M | ||
| Q1 25 | $-18.4M | $72.9M | ||
| Q4 24 | $23.7M | $13.8M | ||
| Q3 24 | $11.7M | — | ||
| Q2 24 | $9.0M | $57.9M | ||
| Q1 24 | $-18.6M | — |
自由现金流OFIXPENG
| Q4 25 | $16.8M | $28.2M | ||
| Q3 25 | $2.5M | $-73.4M | ||
| Q2 25 | $4.5M | $90.9M | ||
| Q1 25 | $-25.1M | $70.5M | ||
| Q4 24 | $15.2M | $12.0M | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $-360.0K | $48.9M | ||
| Q1 24 | $-29.1M | — |
自由现金流率OFIXPENG
| Q4 25 | 7.6% | 8.2% | ||
| Q3 25 | 1.2% | -21.7% | ||
| Q2 25 | 2.2% | 28.0% | ||
| Q1 25 | -13.0% | 19.3% | ||
| Q4 24 | 7.0% | 3.5% | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | -0.2% | 16.3% | ||
| Q1 24 | -15.4% | — |
资本支出强度OFIXPENG
| Q4 25 | 4.9% | 0.8% | ||
| Q3 25 | 4.8% | 0.9% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 3.5% | 0.6% | ||
| Q4 24 | 4.0% | 0.5% | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 4.7% | 3.0% | ||
| Q1 24 | 5.6% | — |
现金转化率OFIXPENG
| Q4 25 | — | 5.89× | ||
| Q3 25 | — | -7.47× | ||
| Q2 25 | — | 34.88× | ||
| Q1 25 | — | 9.02× | ||
| Q4 24 | — | 2.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 10.30× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PENG
| Integrated Memory Segment | $171.6M | 50% |
| Advanced Computing Segment | $115.7M | 34% |
| Optimized LED Segment | $55.7M | 16% |
